We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Corneal cross-linking has been popularly used to prevent ...
Credit: Glaukos. Epioxa does not require the removal of the corneal epithelium, a step usually required by traditional corneal cross-linking procedures, thereby minimizing pain and recovery time.
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio The term cross-linking has recently ...
STAMFORD, Conn., Oct. 7, 2019 /PRNewswire/ -- TECLens, a medical device manufacturer and SERVImed Industrial Spa, an ophthalmic medical devices manufacturer and distributor today announced their ...
SHERBORN, Mass.--(BUSINESS WIRE)--CXL Ophthalmics, Inc., a clinical-stage company developing a minimally-invasive treatment for keratoconus, today published results of the EpiSmart cross-linking Phase ...
Corneal cross-linking is a treatment for an eye problem called keratoconus. In this condition, the front part of your eye, called the cornea, thins out and gets weaker over time. This makes it bulge ...
The US Food and Drug Administration (FDA) has approved Glaukos Corporation’s Epioxa, offering patients living with a rare corneal disease a treatment option that does not require incisions. Epioxa, ...
ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal ...
Corneal cross-linking is an in-office procedure that works to strengthen and stabilize the cornea in eyes that have weakness from keratoconus or ectasia. At Baylor Medicine, our cornea specialists are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results